LOGO-01.png
Burning Rock Received Breakthrough Device Designation from China’s NMPA for its Multi-Cancer Early Detection Test
October 15, 2023 19:18 ET | Burning Rock Biotech Limited
Burning Rock Received Breakthrough Device Designation from China’s NMPA for its Multi-Cancer Early Detection Test
LOGO-01.png
Burning Rock's minimal residual disease (MRD) product supports advancement in early-stage non-small cell lung cancer treatment, with results published in the Cancer Cell
September 07, 2023 22:43 ET | Burning Rock Biotech Limited
GUANGZHOU, China, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”) is delighted to announce that our personalized Minimal...
LOGO-01.png
Burning Rock Reports Second Quarter 2023 Financial Results
August 31, 2023 01:30 ET | Burning Rock Biotech Limited
GUANGZHOU, China, Aug. 31, 2023 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation...
LOGO-01.png
Burning Rock Provides Second Quarter 2023 Business Updates and Schedules Earnings Release on August 31, 2023
August 04, 2023 03:27 ET | Burning Rock Biotech Limited
GUANGZHOU, China, Aug. 04, 2023 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation...
LOGO-01.png
Burning Rock Announces Resignation and Appointment of Directors
June 28, 2023 04:05 ET | Burning Rock Biotech Limited
GUANGZHOU, China, June 28, 2023 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation...
LOGO-01.png
Burning Rock's precision oncology diagnostics product supports advancement in late-stage breast cancer treatment, with results published in the New England Journal of Medicine
June 08, 2023 00:20 ET | Burning Rock Biotech Limited
GUANGZHOU, China, June 08, 2023 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”) is pleased to announce that our flagship comprehensive...
LOGO-01.png
Burning Rock Reports First Quarter 2023 Financial Results
May 30, 2023 00:53 ET | Burning Rock Biotech Limited
GUANGZHOU, China, May 30, 2023 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation...
LOGO-01.png
Burning Rock Provides First Quarter 2023 Business Updates and Schedules Earnings Release on May 30, 2023
April 27, 2023 01:01 ET | Burning Rock Biotech Limited
GUANGZHOU, China, April 27, 2023 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation...
LOGO-01.png
Burning Rock Publishes 2022 Annual Report on Form 20-F
April 20, 2023 22:43 ET | Burning Rock Biotech Limited
GUANGZHOU, China, April 20, 2023 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation...
LOGO-01.png
Burning Rock Reports Fourth Quarter and Full Year 2022 Financial Results
March 28, 2023 02:08 ET | Burning Rock Biotech Limited
GUANGZHOU, China, March 28, 2023 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation...